ERBB2 and ductal breast carcinoma in situ: In a study [146] comparing the three models of 10-year LR prediction, the CPFs +DCIS score showed a slightly higher discrimination power compared to either CPFs alone or combined with HER2 and ER (0.7025, 0.6879, and 0.6825, respectively).